{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:39Z","timestamp":1787162559179,"version":"build-2736575974"},"reference-count":50,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objectives of this study were: (1) to describe burden of rheumatoid arthritis (RA) and trends from 1990 to 2019 using the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) data, (2) to describe age and sex differences in RA and (3) to compare Canada\u2019s RA burden to that of other countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Disease burden indicators included prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life-years (DALYs). GBD estimated fatal and non-fatal outcomes using published literature, survey data and health insurance claims. Data were analysed by Bayesian meta-regression, cause of death ensemble model and other statistical methods. DALYs for Canada were compared with DALYs of countries with similarly high Socio-Demographic Index values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In Canada, the RA prevalence rate increased by 27% between 1990 and 2019, mortality rate decreased by 27%, YLL rate decreased by 30%, YLD increased by 27% and DALY rate increased by 13%, all age standardised. The decline in RA mortality and YLL rates was especially pronounced after 2002. The disease burden was higher in females for all indicators, and DALY rates were higher among older age groups, peaking at age 75\u201379 years. Prevalence and DALYs were higher in Canada compared with global rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Trends in RA burden indicators over time and differences by age and sex have important implications for Canadian policy-makers, researchers and care providers. Early identification and management of RA in women may help reduce the overall burden of RA in Canada.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003533","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T12:20:19Z","timestamp":1705062019000},"page":"e003533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["National burden of rheumatoid arthritis in Canada, 1990\u20132019: findings from the Global Burden of Disease Study 2019 \u2013 a GBD collaborator-led study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-1647","authenticated-orcid":false,"given":"Nejat","family":"Hassen","sequence":"first","affiliation":[{"name":"Arthritis Research Canada, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lacaille","sequence":"additional","affiliation":[{"name":"Arthritis Research Canada, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alandejani","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Sidi","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mansourian","sequence":"additional","affiliation":[{"name":"Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid A","family":"Butt","sequence":"additional","affiliation":[{"name":"School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada"},{"name":"Al Shifa School of Public Health, Al-Shifa Trust Eye Hospital Rawalpindi, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah E","family":"Cahill","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Nutrition, Harvard University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihoghosa Osamuyi","family":"Iyamu","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Knowledge Translation Program, Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J","family":"Lang","sequence":"additional","affiliation":[{"name":"Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwel","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Research and Innovation Division, South Asian Institute for Social Transformation (SAIST), Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjani","family":"Somayaji","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Isfahan Cardiovascular Research Institute, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek A","family":"Kopec","sequence":"additional","affiliation":[{"name":"Arthritis Research Canada, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2025090313300768000_10.1.e003533.1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5114\/aoms.2017.71371","article-title":"Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study","volume":"15","author":"Batko","year":"2019","journal-title":"Arch Med Sci"},{"key":"2025090313300768000_10.1.e003533.2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1351.019"},{"key":"2025090313300768000_10.1.e003533.3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/acr.20041","article-title":"Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005","volume":"62","author":"Sacks","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313300768000_10.1.e003533.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0174-6"},{"key":"2025090313300768000_10.1.e003533.5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.38306","article-title":"The epidemiology of rheumatoid arthritis in Ontario, Canada","volume":"66","author":"Widdifield","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090313300768000_10.1.e003533.6","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s10067-017-3796-1","article-title":"Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study","volume":"36","author":"Jean","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025090313300768000_10.1.e003533.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2025090313300768000_10.1.e003533.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"2025090313300768000_10.1.e003533.9","unstructured":"Global burden of disease collaborative network . Global Burden of Disease Study 2019 (GBD 2019). Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2019. Available: https:\/\/vizhub.healthdata.org\/gbd-compare\/ [accessed 11 May 2023]."},{"key":"2025090313300768000_10.1.e003533.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204627"},{"key":"2025090313300768000_10.1.e003533.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215920"},{"key":"2025090313300768000_10.1.e003533.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2025090313300768000_10.1.e003533.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.22979"},{"key":"2025090313300768000_10.1.e003533.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2025090313300768000_10.1.e003533.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32335-3"},{"key":"2025090313300768000_10.1.e003533.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32203-7"},{"key":"2025090313300768000_10.1.e003533.17","doi-asserted-by":"crossref","DOI":"10.1186\/ar2759","article-title":"Analysis of SKEWED X-Chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases","volume":"11","author":"Chabchoub","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2025090313300768000_10.1.e003533.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.7.793"},{"key":"2025090313300768000_10.1.e003533.19","doi-asserted-by":"crossref","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study","volume":"11","author":"Sokka","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2025090313300768000_10.1.e003533.20","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6358624","article-title":"\u201cBrave men\u201d and \u201cemotional women\u201d: a theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain\u201d","volume":"2018","author":"Samulowitz","year":"2018","journal-title":"Pain Res Manag"},{"key":"2025090313300768000_10.1.e003533.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056937"},{"key":"2025090313300768000_10.1.e003533.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.08.004"},{"key":"2025090313300768000_10.1.e003533.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00326.x"},{"key":"2025090313300768000_10.1.e003533.24","doi-asserted-by":"publisher","DOI":"10.3109\/03009748309102886"},{"key":"2025090313300768000_10.1.e003533.25","first-page":"1456","article-title":"Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis","volume":"30","author":"D\u2019Elia","year":"2003","journal-title":"J Rheumatol"},{"key":"2025090313300768000_10.1.e003533.26","doi-asserted-by":"crossref","DOI":"10.1186\/ar1943","article-title":"Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs","volume":"8","author":"Ideguchi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2025090313300768000_10.1.e003533.27","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"2025090313300768000_10.1.e003533.28","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldq007"},{"key":"2025090313300768000_10.1.e003533.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2010.09.002"},{"key":"2025090313300768000_10.1.e003533.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.01.005"},{"key":"2025090313300768000_10.1.e003533.31","doi-asserted-by":"crossref","first-page":"152031","DOI":"10.1016\/j.semarthrit.2022.152031","article-title":"Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Xu","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313300768000_10.1.e003533.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.11170"},{"key":"2025090313300768000_10.1.e003533.33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110207"},{"key":"2025090313300768000_10.1.e003533.34","unstructured":"Arena CT . Enbrel - immunosupressant for treatment of rehumatoid arthritis, Available: https:\/\/www.clinicaltrialsarena.com\/projects\/enbrel\/"},{"key":"2025090313300768000_10.1.e003533.35","unstructured":"Goverment of Canada . Summary Safetly review - Enbrel (Etanercept) - health Canada. 2016. Available: https:\/\/hpr-rps.hres.ca\/reg-content\/summary-safety-review-detail.php?lang=en&linkID=SSR00098"},{"key":"2025090313300768000_10.1.e003533.36","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X17720366"},{"key":"2025090313300768000_10.1.e003533.37","unstructured":"Lacaille D , Abrahamowicz M , Sayre EC , et al . Biologics and mortality risk in rheumatoid arthritis \u2013 results of a population based study. 2012. Available: https:\/\/acrabstracts.org\/abstract\/biologics-and-mortality-risk-in-rheumatoid-arthritis-results-of-a-population-based-study\/"},{"key":"2025090313300768000_10.1.e003533.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2841-6"},{"key":"2025090313300768000_10.1.e003533.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.52"},{"key":"2025090313300768000_10.1.e003533.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.08.003"},{"key":"2025090313300768000_10.1.e003533.41","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.835"},{"key":"2025090313300768000_10.1.e003533.42","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/rheumatology\/key219","article-title":"Passive smoking in childhood increases the risk of developing rheumatoid arthritis","volume":"58","author":"Seror","year":"2019","journal-title":"Rheumatology"},{"key":"2025090313300768000_10.1.e003533.43","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2001.27719"},{"key":"2025090313300768000_10.1.e003533.44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142109"},{"key":"2025090313300768000_10.1.e003533.45","doi-asserted-by":"crossref","DOI":"10.1186\/ar2123","article-title":"Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study","volume":"9","author":"Benito-Garcia","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2025090313300768000_10.1.e003533.46","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.086918"},{"key":"2025090313300768000_10.1.e003533.47","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev266"},{"key":"2025090313300768000_10.1.e003533.48","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D"},{"key":"2025090313300768000_10.1.e003533.49","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf205"},{"key":"2025090313300768000_10.1.e003533.50","article-title":"Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying rheumatic drug (DMARD) failure: a Cochrane systematic review and network meta-analysis (NMA)","volume":"11","author":"Singh","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:30:18Z","timestamp":1756931418000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/rmdopen-2023-003533"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003533","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}